Elevance Health, Inc. (ELV) Earnings
Elevance Health, Inc.'s most recently reported earnings, recent earnings filings (8-K) and headline annual financials, sourced from SEC EDGAR.
Last reported earnings
Jul 15, 2026
From the latest earnings 8-K
Revenue · FY2025
$199.13B
▲ 12.5%YoY
Diluted EPS · FY2025
$25.21
▼ 1.8%YoY
Reported earnings dates are based on the latest 8-K (Item 2.02) filings. The next earnings date is an estimate projected from ELV's historical reporting pattern, not a company-confirmed date.
Headline financials
| Period | Revenue | Net income | Gross profit | Dil. EPS | Free cash flow | Op. margin | Rev. growth |
|---|---|---|---|---|---|---|---|
| FY2025 | $199.13B | $5.66B | — | $25.21 | $3.17B | 3.6% | +12.5% |
| FY2024 | $177.01B | $5.97B | — | $25.68 | $4.55B | 4.4% | +3.3% |
| FY2023 | $171.34B | $5.99B | — | $25.22 | $6.76B | 5.0% | +9.4% |
| FY2022 | $156.59B | $6.02B | — | $24.81 | $7.25B | 5.4% | +13.0% |
Recent earnings filings
| Filed | Form | Accession |
|---|---|---|
| Jul 15, 2026 | 8-K (2.02) | 0001156039-26-000058EDGAR |
| Apr 22, 2026 | 8-K (2.02) | 0001156039-26-000039EDGAR |
| Jan 28, 2026 | 8-K (2.02) | 0001156039-26-000006EDGAR |
| Oct 21, 2025 | 8-K (2.02) | 0001193125-25-244191EDGAR |
| Jul 17, 2025 | 8-K (2.02) | 0001156039-25-000111EDGAR |
| Apr 22, 2025 | 8-K (2.02) | 0001156039-25-000056EDGAR |
| Apr 17, 2025 | 8-K (2.02) | 0001156039-25-000051EDGAR |
| Jan 23, 2025 | 8-K (2.02) | 0001156039-25-000007EDGAR |
Earnings for companies related to ELV
Never miss a ELV filing.
Get an email when ELV files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Data as of Sep 15, 2026Source: SEC EDGAR.